Gabapentin
Product Images NDC 66116-444
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 66116-444). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medvantx Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Weekly Mean Pain Score (observed Cases In Itt Population): Study 1 (6fa84b06 4292 43c2 888e 3e62b4c19a3d 02)
Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (6fa84b06 4292 43c2 888e 3e62b4c19a3d 03)
Figure 3. Proportion Of Responders (patients With > 50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (6fa84b06 4292 43c2 888e 3e62b4c19a3d 04)
Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients > 12 Years Of Age With Partial Seizures (6fa84b06 4292 43c2 888e 3e62b4c19a3d 05)
Gabapentin 300mg Capsules (6fa84b06 4292 43c2 888e 3e62b4c19a3d 06)
The text contains information about a medication called Gabapentin in capsule form. The website mentioned is medvantx.com. It provides a phone number to be contacted for more information. The medication is manufactured by Teva Pharmaceuticals and is available in 300mg strength and comes in a bottle of 60 capsules. The Lot number mentioned is 00000000. The medication should be stored in a controlled room temperature and should be tightly closed. There is also a warning to keep the medication out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.